相似文献
1
Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial.
J Clin Microbiol. 2006 Jul;44(7):2579-80. doi: 10.1128/JCM.00818-06.
2
Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial.
Br J Dermatol. 2008 Sep;159(3):711-3. doi: 10.1111/j.1365-2133.2008.08648.x. Epub 2008 May 28.
3
In vitro pharmacodynamic characteristics of griseofulvin against dermatophyte isolates of Trichophyton tonsurans from tinea capitis patients.
Med Mycol. 2009 Dec;47(8):796-801. doi: 10.3109/13693780802712523.
4
In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
Int J Antimicrob Agents. 2007 Aug;30(2):157-61. doi: 10.1016/j.ijantimicag.2007.04.004. Epub 2007 Jun 6.
5
In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
Arzneimittelforschung. 1997 Nov;47(11):1257-63.
6
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
J Clin Microbiol. 2004 Dec;42(12):5846-8. doi: 10.1128/JCM.42.12.5846-5848.2004.
7
In vitro activity of sertaconazole against dermatophyte isolates with reduced fluconazole susceptibility.
Chemotherapy. 2003 Sep;49(5):248-51. doi: 10.1159/000072449.
8
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
J Mycol Med. 2020 Jun;30(2):100935. doi: 10.1016/j.mycmed.2020.100935. Epub 2020 Jan 30.
9
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Int J Antimicrob Agents. 2008 Dec;32(6):511-4. doi: 10.1016/j.ijantimicag.2008.05.023. Epub 2008 Sep 13.
10
In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan.
Mycoses. 2004 Dec;47(11-12):503-7. doi: 10.1111/j.1439-0507.2004.01050.x.
引用本文的文献
1
Antifungal Susceptibility of Dermatophyte Isolates from Patients with Chronic and Recurrent Dermatophytosis.
Indian Dermatol Online J. 2024 Dec 26;16(1):110-115. doi: 10.4103/idoj.idoj_192_24. eCollection 2025 Jan-Feb.
2
The unprecedented epidemic-like scenario of dermatophytosis in India: III. Antifungal resistance and treatment options.
Indian J Dermatol Venereol Leprol. 2021;87(4):468-482. doi: 10.25259/IJDVL_303_20.
3
Low activity of sertaconazole against clinical isolates of dermatophyte.
Curr Med Mycol. 2020;6(1):36-41. doi: 10.18502/cmm.6.1.2507.
4
Severe Dermatophytosis and Acquired or Innate Immunodeficiency: A Review.
J Fungi (Basel). 2015 Dec 31;2(1):4. doi: 10.3390/jof2010004.
5
Evaluation of Antifungal Effect of Silver Nanoparticles Against , and .
Iran J Biotechnol. 2015 Dec;13(4):38-42. doi: 10.15171/ijb.1302.
6
Antifungal susceptibility and virulence factors of clinically isolated dermatophytes in Tehran, Iran.
Iran J Microbiol. 2016 Feb;8(1):36-46.
7
Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review.
Indian Dermatol Online J. 2016 Mar-Apr;7(2):77-86. doi: 10.4103/2229-5178.178099.
8
Successful Treatment of Refractory Majocchi's Granuloma with Voriconazole and Review of Published Literature.
Mycopathologia. 2015 Oct;180(3-4):237-43. doi: 10.1007/s11046-015-9902-5. Epub 2015 Jun 5.
9
Fungi on the skin: dermatophytes and Malassezia.
Cold Spring Harb Perspect Med. 2014 Aug 1;4(8):a019802. doi: 10.1101/cshperspect.a019802.
10
In-vitro Activity of 10 Antifungal Agents against 320 Dermatophyte Strains Using Microdilution Method in Tehran.
Iran J Pharm Res. 2013 Summer;12(3):537-45.
本文引用的文献
1
A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis.
J Am Acad Dermatol. 2005 Nov;53(5):798-809. doi: 10.1016/j.jaad.2005.07.028.
2
Pediatric tinea capitis: recognition and management.
Am J Clin Dermatol. 2005;6(4):203-13. doi: 10.2165/00128071-200506040-00001.
3
Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes.
J Clin Microbiol. 2004 Jul;42(7):2977-9. doi: 10.1128/JCM.42.7.2977-2979.2004.
4
A case of black dot ringworm attributable to Trichophyton violaceum: a simple method for identifying macroconidia and microconidia formation by Fungi-Tape and MycoPerm-Blue.
J Dermatol. 2004 May;31(5):424-7. doi: 10.1111/j.1346-8138.2004.tb00697.x.
5
Tinea capitis in Cleveland: survey of elementary school students.
J Am Acad Dermatol. 2003 Feb;48(2):189-93. doi: 10.1067/mjd.2003.109.
6
Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods.
Antimicrob Agents Chemother. 2002 Jun;46(6):1781-4. doi: 10.1128/AAC.46.6.1781-1784.2002.
7
Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates.
J Clin Microbiol. 2000 Jan;38(1):341-4. doi: 10.1128/JCM.38.1.341-344.2000.
8
Treatment of tinea capitis: beyond griseofulvin.
J Am Acad Dermatol. 1999 Jun;40(6 Pt 2):S27-30. doi: 10.1016/s0190-9622(99)70394-4.
9
Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method.
J Am Acad Dermatol. 1999 Jun;40(6 Pt 2):S9-13. doi: 10.1016/s0190-9622(99)70392-0.
Zotero 插件